Heads, Thriftycents, Good article that gives us
Post# of 148292
(Total Views: 579)
Posted On: 03/28/2020 7:47:29 AM
Heads, Thriftycents,
Good article that gives us international exposure. It seems that, gradually, we are getting exposure via the current crisis. Everything COVID is now important (it should be).
Regarding the article, the journalist, Natalie Rahhal apparently talked to Nader. I am inferring this from the way she wrote the article and the details that where incorporated into it, for example:
So, for a health editor of an international newspaper to publish inaccurate information would be risky. I would asume that the patient that is not responding (yet) is one of the last three injected as Patterson and NP referred to the first 4 as responding well.
Again, the above ONLY by deducing from the text. It might be very well that she was misinformed or the patient was too early to show a response (remember that the three last patients where injected very recently).
In any case, even in this circumstance, 6 out of 7 responses (85%) is an extremely good outcome.
We are getting out there and it will be very difficult to ignore CytoDyn any more.
Next week will bring more news.
Good article that gives us international exposure. It seems that, gradually, we are getting exposure via the current crisis. Everything COVID is now important (it should be).
Regarding the article, the journalist, Natalie Rahhal apparently talked to Nader. I am inferring this from the way she wrote the article and the details that where incorporated into it, for example:
Quote:
The drug is given via two injections - one on each side of the abdomen.
For the first patient, a person in their 70s, improvements came almost immediately, and were considerable, from what the doctor overseeing the trial told the company's president.
So, for a health editor of an international newspaper to publish inaccurate information would be risky. I would asume that the patient that is not responding (yet) is one of the last three injected as Patterson and NP referred to the first 4 as responding well.
Again, the above ONLY by deducing from the text. It might be very well that she was misinformed or the patient was too early to show a response (remember that the three last patients where injected very recently).
In any case, even in this circumstance, 6 out of 7 responses (85%) is an extremely good outcome.
We are getting out there and it will be very difficult to ignore CytoDyn any more.
Next week will bring more news.
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼